International Study of clinical performance of LoopampTM SARS-CoV-2 in comparison with real-time reverse transcriptase polymerase chain reaction (RT-PCR) test for COVID-19 diagnosis in Indonesia/The Philippines
Not Applicable
- Conditions
- SARS-CoV-2
- Registration Number
- JPRN-UMIN000049030
- Lead Sponsor
- ational Center for Global Health and Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 256
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with mucosal damage or nasopharyngeal lesions. 2) Patients with nasopharyngeal pain, trauma or nasal surgery within the last 1 month, significantly deviant nasal septum, history of chronically obstructed nasal passages, and severe coagulation disorders. 3) Patients suspected of having used an illicit drug within the last 12 months. 4) Patients determined to be ineligible by the investigator.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method